NCI Resources

NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - October 2001 [Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia] Routine fluorescence in situ hybridization with the MLL probe does not reliably detect two separate signals on one...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - September 2001 Table of ContentsEffects of vascular endothelial growth factor on acute myelogenous leukemia blasts.MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML.Quantification of WT1 mRNA by...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - October 2001 United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Therapeutic options for acute myelogenous leukemia. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - September 2001 Table of ContentsLovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia.Isolation frequency and antimicrobial susceptibility of Pseudomonas aeruginosa bloodstream infections in neutropenic...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - April 2002 Cancer research. Leukemia protein spurs gene silencing. Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells. Expression of CD86 in acute myelogenous leukemia is a marker of ...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - August 2002 The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - February 2002 Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. [Effects of PML and PML-RAR alpha antisense oligonucleotides on promyelocytic leukemia cell line NB4] Immunocytochemical...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - January 2002 Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia. Intercellular adhesion molecule-1 in extravasation of normal mononuclear and leukaemia cells....
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - July 2002 Agent Orange no longer linked to childhood AML. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification [Examination of human herpesvirus-6 antibody in blood...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - June 2002 Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - March 2002 Childhood leukemia and magnetic fields in infant incubators. Effect of cytokines on growth and differentiation of leukaemic cells with translocation t(6;9)(p23;q34). Synergic effects of arsenic trioxide and cAMP during acute promyelocytic ...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - May 2002 Antibody status to HHV-6 in children with leukaemia. Immunologic manipulation in AML: from bench to bedside. Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Expression of the Gb3/CD77...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - October 2002 [Expression of NM23-H(1) mRNA in acute leukemia] Bone marrow reticulin fibrosis at diagnosis in promyelocytic leukaemia treated with all-trans retinoic acid has no adverse prognosis. Cancer epigenetics and methylation. Serum immunoglobulins...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of AML - September 2002 [Mast cell leukemia] Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK. Structural...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - April 2002 Advances in the treatment of relapsed acute promyelocytic leukemia. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy] Development of hepatic veno-occlusive disease after Mylotarg infusion for...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - August 2002 [Management of childhood acute leukemia with standard protocol for increasing the long-time disease free survival rate] [Pure red cell aplasia after allogeneic peripheral blood stem cell transplantation: a case report and literature...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - February 2002 In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells. Very late appearance of acute graft-versus-host disease after tapering immunosuppression. ATRA(ouble) in the treatment of acute promyelocytic...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - January 2002 Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - July 2002 Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: Arsenic trioxide newly joins treatment strategies for acute promyelocytic leukemia. Autologous...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - June 2002 Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - March 2002 Mechanism-based therapy for leukemia: a lesson from ATRA therapy. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Efficacy of granulocyte...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - May 2002 Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Treatment and outcome of infants with acute myeloid leukemia. Farnesylpyridinium, an analog of isoprenoid farnesol,...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - October 2002 Introduction. Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a Quality of life through rehabilitation at end of life. Bone marrow reticulin fibrosis at...
NCI CANCERLIT^® Search: Therapy of Acute Myeloid Leukemia - September 2002 [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic Colony-stimulating factors: beyond the effects on hematopoiesis. A graft-versus-tumor effect in a patient...